The antibody targets a protein encoded by the SPBC1604.06c gene in S. pombe. While functional data for this specific antibody are not publicly disclosed, insights about S. pombe biology provide context:
Genomic Role: S. pombe genes like SPBC1604.06c are often involved in essential processes such as cell cycle regulation, DNA repair, or stress response.
Related Research: Studies on fission yeast cell wall synthesis (e.g., Sup11p in β-1,6-glucan formation [Source 4]) highlight the importance of antibodies in elucidating pathways linked to septation and glycosylation.
Antibodies against S. pombe proteins are critical for:
Localization Studies: Mapping protein expression patterns during mitotic or meiotic phases.
Functional Knockdowns: Validating gene-editing outcomes (e.g., CRISPR/Cas9 mutants).
Interactome Analysis: Identifying binding partners via co-immunoprecipitation.
Epitope Uncharacterized: The exact binding region (linear/conformational) remains undefined.
Validation Data: No peer-reviewed studies explicitly using this antibody were identified in public databases.
Commercial Specificity: Cross-reactivity with homologs in other fungi (e.g., Saccharomyces cerevisiae) is untested.
Antibody performance in S. pombe research often depends on:
| Feature | SPBC1604.06c Antibody | Typical S. pombe Antibodies |
|---|---|---|
| Target Specificity | Presumed high (Uniprot O94372) | Validated via KO strains |
| Applications | Assumed broad | Confirmed in WB/IP/IF |
| Commercial Availability | Yes (Cusabio) | Varies by vendor |
To maximize utility, researchers should:
Validate specificity using SPBC1604.06c knockout strains.
Publish datasets in open repositories (e.g., Zenodo) to build community trust.
Explore structural biology applications (e.g., cryo-EM with tagged proteins).
KEGG: spo:SPBC1604.06c
STRING: 4896.SPBC1604.06c.1
SPBC1604.06c likely represents a gene locus in Schizosaccharomyces pombe (fission yeast), similar to how other proteins such as Ste20 function in Saccharomyces cerevisiae. Generating antibodies against this protein enables researchers to track its localization, expression levels, and interactions with other cellular components. Based on studies of similar yeast proteins, SPBC1604.06c may function in signaling pathways analogous to how Ste20 participates in MAPK cascades .
Antibodies against yeast proteins like SPBC1604.06c serve multiple research purposes including protein detection in western blots, localization studies via immunofluorescence, immunoprecipitation experiments to identify interacting partners, and potentially functional inhibition studies. The specific protein domain targeted by the antibody greatly influences its application range and performance in different experimental contexts .
Researchers studying signaling pathways, protein localization, or protein-protein interactions would benefit from reliable SPBC1604.06c antibodies, as these tools can provide insights into cellular functions that genetic approaches alone cannot offer. The value of these antibodies increases significantly when the target protein has multiple functional domains or undergoes post-translational modifications that affect its activity.
Specificity validation is crucial for antibodies against yeast proteins like SPBC1604.06c. The first validation step involves western blot analysis comparing wild-type yeast lysates with those from a strain where SPBC1604.06c has been deleted or tagged. A specific antibody should show a band at the predicted molecular weight in wild-type samples that disappears in knockout strains or shifts in tagged strains .
Immunofluorescence microscopy provides another validation method where the antibody's staining pattern should correspond to the expected localization and be absent in knockout strains. For membrane-associated proteins, this pattern may resemble the plasma membrane localization observed with proteins like Ste20, which shows specific recruitment to sites of polarized growth .
Competitive binding assays offer additional specificity confirmation. Pre-incubating the antibody with purified SPBC1604.06c protein or the immunizing peptide should abolish signal in both western blots and immunofluorescence experiments. Cross-reactivity tests against related yeast proteins are also essential, especially considering the conserved nature of many signaling proteins like those in the PAK family .
Optimal preservation of antibodies against yeast proteins requires careful attention to storage conditions. Most purified antibodies maintain activity when stored at -20°C in small aliquots containing glycerol (typically 30-50%) to prevent freeze-thaw damage. For long-term storage, -80°C is preferable, especially for monoclonal antibodies that may be more susceptible to denaturation .
Buffer composition significantly impacts antibody stability. PBS with 0.02% sodium azide prevents microbial contamination, while addition of carrier proteins like BSA (0.1-1%) reduces non-specific adsorption to tube walls. For antibodies that recognize conformational epitopes, preserving structural integrity is particularly important, as proteins like SPBC1604.06c may contain multiple functional domains similar to Ste20's CRIB and BR domains .
Repeated freeze-thaw cycles should be strictly avoided as they can lead to antibody fragmentation and aggregation, resulting in decreased affinity and increased background. Creating working dilutions for immediate use and storing concentrated stock solutions separately maximizes antibody lifespan. Proper documentation of storage conditions, freeze-thaw cycles, and observed performance changes helps track potential deterioration over time.
SPBC1604.06c antibodies can be instrumental in studying protein-membrane interactions through various advanced techniques. Membrane fractionation studies combined with immunoblotting allow researchers to determine whether SPBC1604.06c associates with specific membrane compartments. This approach helped identify that proteins like Ste20 require both a CRIB domain for Cdc42 binding and a basic-rich (BR) domain for direct membrane interaction .
Immunogold electron microscopy offers nanometer-scale resolution of SPBC1604.06c localization at membranes. For this technique, thin sections of yeast cells are incubated with the primary antibody against SPBC1604.06c, followed by a gold-conjugated secondary antibody. The distance between gold particles and the plasma membrane can be precisely measured to determine how closely SPBC1604.06c associates with the membrane, similar to studies that revealed the importance of membrane localization for Ste20 function .
In vitro liposome-binding assays can also be coupled with SPBC1604.06c antibodies to assess direct lipid interactions. Purified SPBC1604.06c protein is incubated with synthetic liposomes of defined composition, and protein-liposome complexes are separated by centrifugation. Western blotting using the antibody can then quantify the amount of protein bound to different lipid compositions, potentially revealing lipid preferences similar to how electrostatic interactions mediate membrane binding of signaling proteins .
Co-immunoprecipitation (co-IP) using SPBC1604.06c antibodies requires careful optimization of lysis and binding conditions. The lysis buffer should preserve protein-protein interactions while efficiently solubilizing membrane-associated proteins. For yeast proteins that associate with the plasma membrane, buffers containing 0.5-1% NP-40 or digitonin often maintain interactions better than stronger detergents like SDS or deoxycholate .
The antibody immobilization method significantly impacts co-IP efficiency. Pre-coupling the SPBC1604.06c antibody to Protein A/G beads before adding cell lysate can reduce background by eliminating non-specific protein binding to the beads during the antibody-antigen binding step. This approach has proven effective in studies identifying binding partners of signaling proteins in yeast MAPK pathways .
To distinguish true interactors from contaminants, quantitative proteomics approaches comparing SPBC1604.06c immunoprecipitates with control samples are essential. Controls should include IgG from the same species as the SPBC1604.06c antibody and immunoprecipitations from SPBC1604.06c knockout strains. The table below outlines a recommended co-IP protocol:
| Step | Procedure | Critical Considerations |
|---|---|---|
| 1 | Cell lysis | Use buffer with 50mM Tris (pH 7.5), 150mM NaCl, 0.5% NP-40, protease inhibitors |
| 2 | Pre-clearing | Incubate lysate with Protein A/G beads for 1h at 4°C |
| 3 | Immunoprecipitation | Add 2-5μg antibody per mg of protein, incubate overnight at 4°C |
| 4 | Washing | Perform 5 washes with decreasing detergent concentration |
| 5 | Elution | Use gentle elution with peptide or acidic glycine buffer |
| 6 | Analysis | Mass spectrometry or immunoblotting for suspected partners |
Genetically encoded intrabodies represent another powerful approach. By cloning the variable regions of a validated SPBC1604.06c antibody and expressing them as fusion proteins with fluorescent tags in yeast cells, researchers can track the endogenous protein. This approach requires screening to identify antibody fragments that fold correctly in the reducing environment of the cytoplasm but has been successfully applied to track signaling proteins in various cell types .
For studies requiring high temporal resolution of protein dynamics, researchers can combine antibody-based detection with optogenetic approaches. By fusing SPBC1604.06c with a photosensitive domain and using antibodies to detect its activation-dependent conformational changes or relocalization, researchers can monitor how the protein responds to various stimuli in real time. Similar approaches have revealed how proteins like Ste20 dynamically relocalize during signaling events to activate MAPK cascades .
Designing epitopes for SPBC1604.06c antibodies requires careful consideration of protein structure and function. Based on studies of similar signaling proteins like Ste20, SPBC1604.06c might contain multiple functional domains such as catalytic regions, membrane-binding motifs, or protein-interaction domains. Generating antibodies against each domain provides tools to dissect distinct functions .
For membrane-binding domains, choose epitopes from regions rich in basic residues that might mediate lipid interactions, similar to the BR domain in Ste20. These antibodies can help determine whether SPBC1604.06c interacts with membranes through electrostatic mechanisms. Ensure the selected epitope is not buried within the protein structure when membrane-bound, as this would prevent antibody accessibility in native conditions .
When designing epitopes for antibodies against protein-interaction domains, analyze sequence conservation across species to identify unique regions that distinguish SPBC1604.06c from related proteins. Avoid highly conserved catalytic domains if specificity is crucial. The table below outlines a systematic approach to epitope selection for different functional domains:
| Domain Type | Epitope Selection Criteria | Applications | Potential Limitations |
|---|---|---|---|
| Catalytic domain | Moderately conserved regions outside the active site | Activity assays, conformational studies | May cross-react with related kinases |
| Membrane-binding motif | Basic-rich sequences, accessible when membrane-bound | Localization studies, lipid-binding assays | May disrupt electrostatic interactions |
| Protein-interaction motif | Unique sequences in binding interfaces | Interaction inhibition, complex detection | May block functional interactions |
| Regulatory region | Phosphorylation-sensitive sequences | Activation state detection | Epitope may be masked by conformation |
High background signal represents one of the most common issues when using antibodies against yeast proteins. This often results from cross-reactivity with related proteins or non-specific binding to cell components. To reduce background, implement more stringent washing conditions and include blocking agents such as 5% BSA or 5% non-fat milk in both blocking and antibody incubation steps. Pre-adsorbing the antibody with acetone powder prepared from knockout strains can also significantly reduce cross-reactivity .
Difficulty detecting membrane-associated proteins like SPBC1604.06c often stems from inadequate extraction techniques. Membrane proteins require specialized lysis methods that effectively solubilize lipid-bound proteins without disrupting epitope structure. Consider using a combination of non-ionic detergents (e.g., 1% Triton X-100) with brief sonication when preparing samples for immunoblotting. For particularly challenging extractions, specialized detergents like digitonin or dodecylmaltoside may better preserve native protein conformations .
Variable antibody performance across different experimental conditions can be addressed through systematic optimization. For each new experimental system, create a validation matrix testing different antibody concentrations, incubation times, and buffer compositions. Document these parameters thoroughly to ensure reproducibility. When working with formaldehyde-fixed samples, implementing antigen retrieval techniques such as citrate buffer treatment (10mM sodium citrate, pH 6.0, 95°C for 20 minutes) can significantly restore epitope accessibility .
Optimizing immunofluorescence for yeast proteins requires addressing the challenge of cell wall penetration. Enzymatic digestion with lyticase or zymolyase (1mg/ml for 15-30 minutes at 30°C) creates spheroplasts that allow antibody access while maintaining cellular structures. The digestion time requires careful optimization - insufficient digestion prevents antibody penetration while excessive treatment disrupts cell morphology and protein localization .
Fixation methods significantly impact epitope preservation and accessibility. For membrane-associated proteins like SPBC1604.06c that might share properties with Ste20, a combination approach often works best: brief formaldehyde fixation (3.7% for 10 minutes) followed by methanol/acetone treatment (-20°C for 6 minutes) can preserve both membrane association and protein conformations. This approach has successfully revealed the polarized membrane localization of signaling proteins in yeast cells .
Background reduction requires specialized blocking solutions for yeast immunofluorescence. A blocking buffer containing 1% BSA, 0.5% Triton X-100, and 5% normal serum from the secondary antibody species helps minimize non-specific binding. For detecting proteins at the yeast cell periphery, deconvolution microscopy or super-resolution techniques like structured illumination microscopy (SIM) can significantly improve resolution of membrane-localized signals. The following table presents an optimized step-by-step protocol:
| Step | Procedure | Optimization Notes |
|---|---|---|
| 1 | Cell growth | Harvest at mid-log phase (OD600 0.6-0.8) |
| 2 | Fixation | 3.7% formaldehyde (10 min), then -20°C methanol/acetone (6 min) |
| 3 | Spheroplasting | 1mg/ml zymolyase in sorbitol buffer (30 min, 30°C) |
| 4 | Permeabilization | 0.5% Triton X-100 in PBS (5 min) |
| 5 | Blocking | 5% normal serum, 1% BSA in PBS (1 hour) |
| 6 | Primary antibody | 1:100-1:500 dilution, overnight at 4°C |
| 7 | Washing | 5× with PBS + 0.1% Tween-20 |
| 8 | Secondary antibody | 1:500-1:2000, fluorophore-conjugated, 1 hour at RT |
| 9 | Nuclear staining | DAPI (1μg/ml) for 5 minutes |
| 10 | Mounting | Anti-fade mounting medium |
Quantitative analysis of SPBC1604.06c localization requires combining immunofluorescence using validated antibodies with digital image analysis. To track changes throughout the cell cycle, synchronize yeast cultures using methods like alpha-factor arrest-release (for S. cerevisiae) or lactose gradient centrifugation (for S. pombe), then fix cells at defined time points for immunostaining. Image analysis software such as ImageJ with the JACoP plugin can calculate colocalization coefficients between SPBC1604.06c and known markers of cell cycle stages .
For stimulus-response studies, develop a quantification approach that measures membrane-to-cytoplasm signal ratios. This approach was effective in studies of Ste20, where membrane recruitment was quantified in response to pheromone stimulation. Specifically, measure fluorescence intensity along line profiles drawn across cells, calculating the ratio between membrane peaks and cytoplasmic baseline. This method can detect subtle redistribution events that might be missed by visual inspection alone .
Time-dependent changes in localization can be analyzed using statistical approaches that account for cell-to-cell variability. Collect data from at least 100 cells per condition across three independent experiments, and present results as box plots showing median, quartiles, and outliers rather than simple bar graphs with standard deviation. The following quantification parameters have proven useful for membrane-localized proteins:
Distinguishing specific from non-specific signals requires implementing multiple controls in each experiment. Genetic controls are most powerful: compare results between wild-type cells and SPBC1604.06c deletion strains. Any signal persisting in knockout samples represents non-specific binding. Additionally, comparing staining patterns between antibodies targeting different epitopes of SPBC1604.06c helps confirm specific detection, as genuine signals should show substantial overlap despite potential differences in intensity .
Competition assays provide another layer of validation. Pre-incubate the antibody with excess purified antigen or immunizing peptide before application in your experiment. Specific signals should be significantly reduced or eliminated, while non-specific binding typically remains unchanged. This approach is particularly valuable when genetic knockouts are not available or when validating new experimental conditions .
Quantitative analysis methods help distinguish real signals from background noise. In immunoblotting, calculate signal-to-noise ratios by comparing band intensity to adjacent blank regions. For immunofluorescence, analyze intensity profiles across cellular structures - specific signals typically follow known biological distributions (like membrane localization patterns seen with Ste20), while non-specific signals often appear as random puncta or diffuse staining. Document specific criteria used to classify signals as positive versus negative to ensure consistency across experiments .
Proximity ligation assays (PLA) using SPBC1604.06c antibodies offer a powerful approach to visualize protein interactions in situ. This technique requires primary antibodies from different species against SPBC1604.06c and its suspected interaction partner. When these proteins are in close proximity (<40nm), complementary oligonucleotides attached to secondary antibodies enable rolling-circle amplification, generating fluorescent spots at interaction sites. This method can reveal dynamic changes in protein complexes during signaling, similar to how scaffold proteins modulate signaling complexes in MAPK pathways .
Antibody-based FRET (Förster Resonance Energy Transfer) provides another approach to detect protein interactions with nanometer resolution. By labeling anti-SPBC1604.06c antibodies with donor fluorophores and antibodies against interaction partners with acceptor fluorophores, energy transfer between fluorophores indicates close proximity. This technique is particularly valuable for studying how membrane-localized interactions might change during signaling events, as seen with the regulation of MAPK pathways by scaffold proteins .
Chemical crosslinking followed by immunoprecipitation with SPBC1604.06c antibodies can capture transient interactions. Treat cells with membrane-permeable crosslinkers like DSP (dithiobis(succinimidyl propionate)) before lysis and immunoprecipitation. Crosslinked complexes can then be analyzed by mass spectrometry to identify interaction changes during signaling. This approach has revealed how interactions between proteins like Ste20 and scaffold proteins dynamically change during signal transmission . The table below summarizes methods for detecting interaction changes:
| Method | Spatial Resolution | Temporal Resolution | Key Advantages | Limitations |
|---|---|---|---|---|
| Co-IP with stimulus time course | None (cell population) | Minutes | Identifies novel partners | Cannot resolve subcellular location |
| Proximity Ligation Assay | ~40nm | Fixed timepoints | Visualizes interactions in situ | Requires antibodies from different species |
| FRET with antibody conjugates | 1-10nm | Seconds | High sensitivity for close interactions | Complex controls required |
| BiFC with intrabodies | 7-10nm | Hours (protein maturation) | Direct visualization in living cells | Irreversible complex formation |
| Crosslinking-MS | Molecular contact | Minutes | Identifies interaction interfaces | Complex data analysis |
Antibodies against SPBC1604.06c can serve as valuable tools for comparative studies across fungal species to trace evolutionary conservation of signaling pathways. If SPBC1604.06c functions in pathways analogous to Ste20-dependent signaling in S. cerevisiae, antibodies that recognize conserved epitopes might cross-react with homologs in other fungi. Systematic testing of the antibody against protein extracts from diverse fungal species, followed by mass spectrometry validation of detected bands, could map the evolutionary distribution of this signaling component .
Cross-species immunoprecipitation studies using SPBC1604.06c antibodies can reveal conservation of protein interaction networks. By performing immunoprecipitations in different yeast species and comparing the interactome composition, researchers can identify both conserved core interactions and species-specific adaptations. This approach has revealed how scaffold proteins and their interaction partners have evolved to maintain signaling specificity despite increasing proteome complexity .
Structural conservation can be assessed through epitope mapping across species. By determining which epitopes of SPBC1604.06c are recognized by the antibody in different fungal homologs, researchers can infer structural conservation of functional domains. This information, combined with sequence analysis, helps reconstruct the evolutionary history of domain acquisition and specialization in signaling proteins, similar to how the functional interplay between CRIB and BR domains has been studied in Cdc42 effectors .
Integrating SPBC1604.06c antibodies with microfluidic systems enables dynamic single-cell analysis of protein expression and localization. By immobilizing yeast cells in microfluidic chambers with continuous media flow, researchers can perform immunostaining without cell loss while precisely controlling the timing of fixation after stimulus addition. This approach allows correlation between single-cell phenotypes and protein localization patterns, revealing heterogeneity in signaling responses across populations .
Mass cytometry (CyTOF) combined with SPBC1604.06c antibodies conjugated to rare earth metals offers high-dimensional analysis of signaling states. This technique allows simultaneous measurement of dozens of parameters in single cells, enabling researchers to correlate SPBC1604.06c localization or modification state with other signaling components. While primarily developed for mammalian cells, protocols have been adapted for yeast, opening new possibilities for comprehensive signaling network analysis at single-cell resolution .
Spatial transcriptomics approaches can be enhanced by using SPBC1604.06c antibodies to connect protein localization with local mRNA expression. By performing immunofluorescence for SPBC1604.06c followed by in situ RNA sequencing, researchers can investigate whether protein localization correlates with specific transcriptional states in individual cells. This combined approach could reveal how membrane-localized signaling proteins like those in MAPK pathways influence local translation or mRNA localization, providing insights into spatial organization of cellular responses .
Computational modeling can transform quantitative immunofluorescence data from SPBC1604.06c antibodies into dynamic simulations of protein behavior. By extracting parameters such as membrane-to-cytoplasm ratios across many cells and timepoints, researchers can develop ordinary differential equation (ODE) models that predict how SPBC1604.06c localization changes in response to various stimuli. These models can generate testable hypotheses about the kinetics of membrane association and dissociation, similar to how modeling has enhanced understanding of ultrasensitivity in MAPK cascades .
Agent-based modeling approaches can integrate antibody-derived localization data with information about protein-protein interactions to simulate spatial aspects of signaling. By representing individual SPBC1604.06c molecules and their binding partners as computational agents that move and interact according to experimentally determined rules, researchers can explore how spatial organization impacts signaling outcomes. This approach is particularly valuable for understanding how membrane localization influences complex formation efficiency and signal propagation, as observed in scaffold-mediated signaling .
Systems biology approaches integrating multiple levels of biological information would benefit substantially from well-characterized SPBC1604.06c antibodies. These tools could help connect protein localization and interaction data with transcriptomic, proteomic, and metabolomic datasets to build comprehensive models of cellular signaling networks. Such multi-omics integration would be particularly powerful for understanding context-dependent signaling behaviors, similar to how scaffold proteins modulate MAPK pathway outputs in different environmental conditions .
Synthetic biology applications could leverage SPBC1604.06c antibodies to evaluate the performance of engineered signaling pathways. By monitoring the localization and interactions of both endogenous SPBC1604.06c and synthetic signaling components, researchers could troubleshoot and optimize artificial circuits. This approach would be particularly valuable for engineering yeast-based biosensors or signal processing systems that interface with natural cellular machinery, drawing on principles established through studies of modular signaling domains in proteins like Ste20 .
Evolutionary and comparative biology studies across fungi could use SPBC1604.06c antibodies to trace the diversification of signaling pathways. By examining how protein localization patterns and interaction networks differ between species, researchers could reconstruct the evolutionary history of signaling systems and identify lineage-specific adaptations. This knowledge would contribute to our understanding of how fundamental cellular processes are conserved yet adaptable throughout fungal evolution, complementing insights gained from studies of conserved signaling components like Cdc42 effectors across species .
Selecting appropriate SPBC1604.06c antibodies requires systematic evaluation against specific experimental requirements. Begin by determining which protein domains or modifications are most relevant to your research question. If studying membrane interactions, prioritize antibodies targeting regions similar to the BR domain in Ste20 that mediates lipid binding. For activation studies, antibodies recognizing phosphorylation-specific epitopes would be more valuable .
Comprehensive validation across multiple techniques is essential before committing to extensive experiments. Test each antibody candidate in at least three different applications (e.g., western blotting, immunoprecipitation, and immunofluorescence) using both positive controls (wild-type cells) and negative controls (knockout strains or competing peptides). Document specificity, sensitivity, and reproducibility for each application, as performance often varies substantially between techniques. The table below provides a framework for systematic antibody evaluation:
| Validation Parameter | Experimental Approach | Acceptance Criteria |
|---|---|---|
| Specificity | Western blot with WT and KO samples | Single band at correct MW in WT, absent in KO |
| Sensitivity | Dilution series in primary application | Detectable signal at ≤1:1000 dilution |
| Cross-reactivity | Testing against related proteins | <10% signal compared to SPBC1604.06c |
| Reproducibility | Replicate experiments | CV <15% across 3+ independent tests |
| Application versatility | Testing in multiple techniques | Successful performance in ≥2 applications |
| Lot-to-lot consistency | Testing different production batches | <20% variation in signal intensity |
Consider the antibody format most appropriate for your applications. For co-localization studies using immunofluorescence microscopy, ensuring compatibility with other primary antibodies is crucial - select SPBC1604.06c antibodies raised in species different from those used for other targets. For chromatin immunoprecipitation or other applications requiring native protein recognition, antibodies against linear epitopes may underperform compared to those recognizing conformational epitopes .